
Predictive Oncology, Visionary, Cocrystal Pharma, Sidus Space, Turbo Energy, Biodexa Pharmaceuticals, and JetBlue Airways are the seven Penny stocks to watch today, according to MarketBeat’s stock screener tool. Penny stocks are low-priced shares of small companies—typically quoted under $5 per share by the U.S. SEC—often traded on over-the-counter markets or on small exchanges. They tend to have low liquidity, wide bid-ask spreads and high volatility, making them higher-risk and more susceptible to price manipulation than larger, exchange-listed stocks. These companies had the highest dollar trading volume of any Penny stocks within the last several days.
Predictive Oncology (POAI)
Predictive Oncology Inc. operates as a science-driven company on the oncology drug discovery. It provides various solutions for the oncology drug development. The company, through the integration of scientific rigor and machine learning, has developed the ability to advance molecules into medicine by introducing human diversity earlier into the discovery process with the pairing of artificial intelligence and the biobank of approximately 150K tumor samples.
Visionary (GV)
Visionary Holdings Inc. provides private online and in person educational programs and services to Canadian and international students that reside in Canada and internationally. The company's educational programs include Ontario secondary school diploma, career-oriented two-year college and four-year university diploma programs, vocational education programs, and master programs.
Read Our Latest Research Report on GV
Cocrystal Pharma (COCP)
Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, norovirus, and respiratory virus infections.
Read Our Latest Research Report on COCP
Sidus Space (SIDU)
Sidus Space, Inc., a space-as-a-service company, engages in the design, manufacture, launch, and data collection of commercial satellite worldwide. Its space services include satellite/space hardware manufacturing; Low Earth Orbit (LEO) launch and deployment services; and space-based geospatial intel, imagery, and data analytics.
Read Our Latest Research Report on SIDU
Turbo Energy (TURB)
Turbo Energy, S.A. designs, develops, and distributes equipment for the generation, management, and storage of photovoltaic energy in Spain, rest of Europe, and internationally. The company offers lithium-ion batteries; inverters; photovoltaic modules; Go Solar, a portable photovoltaic product; and Sunbox, an AI based software system that monitors the generation, use, and management of photovoltaic energy.
Read Our Latest Research Report on TURB
Biodexa Pharmaceuticals (BDRX)
Biodexa Pharmaceuticals Plc, a clinical stage biopharmaceutical company, focuses on developing a pipeline of products for the treatment of Type 1 diabetes and rare/orphan cancers of the brain. Its lead product candidate Tolimidone, a selective activator of the lyn kinase enzyme, currently under Phase II studies for the treatment of Type 1 diabetes.
Read Our Latest Research Report on BDRX
JetBlue Airways (JBLU)
JetBlue Airways Corporation provides air transportation services. The company operates a fleet of Airbus A321, Airbus A220, Airbus A321neo, Airbus A320 Restyled, Airbus A320, Airbus A321 with Mint, Airbus A321neo with Mint, Airbus A321neoLR with Mint, and Embraer E190 aircraft. It also serves 100 destinations across the United States, the Caribbean and Latin America, Canada, and Europe.
Read Our Latest Research Report on JBLU
Further Reading
- MarketBeat’s Top Five Stocks to Own in April 2026
- CrowdStrike Stock Drops on AI Fears—Is This a Buying Opportunity?
- Conagra Stock Yields Nearly 9% After a 60% Decline—Time to Buy?
- Down 75% From Its High, How Much Lower Can Nike Get?
- Frozen Out: Lamb Weston Beats Earnings, but the Stock Still Slides
- Lilly’s Next Empire: A $10 Billion Bet on AI and Neuroscience
